Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.

Clinical trial NCT04213664 · UNKNOWN

Trial details

NCT number: NCT04213664
Sponsor: Corporacion Parc Tauli
Status: UNKNOWN
Study type: OBSERVATIONAL

Renal Cell Carcinoma Progression Lymphocyte Disorder Monocytosis Local Disease

Start date: 2019-12-31
Primary completion: 2020-01-02
Enrollment: 4666

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.